Anti-osteopontin antibodies replicate the tumor suppression phenotype in thrombin cleavage-resistant osteopontin knock-in mice
- 7 August 2025
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 23 (11) , 3691-3703
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs (VA I01 BX005148)
- U.S. Department of Veterans Affairs (I01 BX005734-01A2)
- School of Medicine, Stanford University
This publication has 38 references indexed in Scilit:
- Methods to Investigate Thrombin Cleavage of Osteopontin (OPN)2023
- The critical role of osteopontin (OPN) in fibrotic diseasesCytokine & Growth Factor Reviews, 2023
- Post-translational regulation and proteolytic activity of the metalloproteinase ADAMTS8Journal of Biological Chemistry, 2021
- The multiple functions and mechanisms of osteopontinClinical Biochemistry, 2018
- Catalpol suppressed proliferation, growth and invasion of CT26 colon cancer by inhibiting inflammation and tumor angiogenesisBiomedicine & Pharmacotherapy, 2017
- Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrinJournal of Cellular Biochemistry, 2012
- Thrombin‐activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritisArthritis & Rheumatism, 2009
- Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancerNature Reviews Cancer, 2008
- Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibodyInternational Immunopharmacology, 2007
- Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cellsNature Immunology, 2006